ferumoxytol
Showing 1 - 25 of 102
Panvascular Disease Trial in Nanjing (Ferumoxytol Enhanced Magnetic Resonance Angiography( FE-MRA);Coronary/Renal /Lower artery
Recruiting
- Panvascular Disease
- Ferumoxytol Enhanced Magnetic Resonance Angiography( FE-MRA);Coronary/Renal /Lower artery Arteriography
- Ferumoxytol Enhanced Magnetic Resonance Venography( FE-MRV), Computed Tomography Pulmonary Angiography, Ultrasound for Lower Extremity Deep Vein.
-
Nanjing, Jiangsu, ChinaFirst Affiliated Hospital of Nanjing Medical University
Nov 13, 2023
Osteomyelitis Trial in Albuquerque (Ferumoxides 11.2Mg Solution for Injection)
Completed
- Osteomyelitis
- Ferumoxides 11.2Mg Solution for Injection
-
Albuquerque, New MexicoUniversity of New Mexico
Jul 17, 2023
A Novel Ferumoxytol-enhanced Cardiac Magnetic Resonance Imaging
Recruiting
- Heart Aneurysm
- Superparamagnetic Iron Oxide Nanoparticles
-
Nanjing, Jiangsu, ChinaThe First Affiliated Hospital of Nanjing Medical University
Nov 18, 2023
Apical Periodontitis, Pulp Disease, Dental Trial in Philadelphia (Iron oxide nanoparticles treatment Ferumoxytol/H2O2, NaOCl,
Completed
- Apical Periodontitis
- Pulp Disease, Dental
- Iron oxide nanoparticles treatment Ferumoxytol/H2O2
- +2 more
-
Philadelphia, PennsylvaniaUniversity of Pennsylvania
Oct 25, 2023
Multiple Sclerosis Trial run by the National Institute of Neurological Disorders and Stroke (NINDS) (Ferumoxytol)
Completed
- Multiple Sclerosis
- Ferumoxytol
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Pregnancy Related, Anemia, Iron Deficiency Trial in Stanford (Ferumoxytol Injection [Feraheme], Ferrous Sulfate)
Enrolling by invitation
- Pregnancy Related
- Anemia, Iron Deficiency
- Ferumoxytol Injection [Feraheme]
- Ferrous Sulfate
-
Stanford, CaliforniaStanford University School of Medicine/Lucile Packard Childrens
Dec 9, 2022
Ferumoxytol Enhanced Hyperfine Low Field Strength MRI
Completed
- Anemia, Hemolytic
- Hyperfine Portable MRI
-
Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
Dec 16, 2022
Childhood Brain Tumor, Recurrent Childhood Brain Tumor Trial in Portland (Dynamic Contrast-Enhanced Magnetic Resonance Imaging,
Completed
- Childhood Brain Neoplasm
- Recurrent Childhood Brain Neoplasm
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 11, 2022
Iron Deficiency Anemia of Pregnancy Trial in Tucson (Ferrous sulfate 325mg, Ferumoxytol)
Completed
- Iron Deficiency Anemia of Pregnancy
- Ferrous sulfate 325mg
- Ferumoxytol
-
Tucson, ArizonaUniversity of Arizona
Sep 5, 2022
CNS Tumor, Cranial Nerve Disorder, Metastatic Malignant Tumor in the Brain Trial in Portland (Ferumoxytol, Gadolinium, Magnetic
Recruiting
- Central Nervous System Neoplasm
- +2 more
- Ferumoxytol
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Jun 2, 2022
Anemia Trial in Baltimore (ferumoxytol, moxifloxacin, )
Completed
- Anemia
- ferumoxytol
- +2 more
-
Baltimore, Maryland(unnamed)
Apr 1, 2022
Glioblastoma, Glioblastoma Multiforme Trial (Ferumoxytol injection, Pharmacological ascorbate, External beam radiation therapy)
Not yet recruiting
- Glioblastoma
- Glioblastoma Multiforme
- Ferumoxytol injection
- +3 more
- (no location specified)
Mar 3, 2022
Lung Carcinoma Metastatic in the Brain, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Portland (drug, other, procedure,
Terminated
- Lung Carcinoma Metastatic in the Brain
- Stage IV Lung Non-Small Cell Cancer AJCC v7
- Ferumoxytol
- +3 more
-
Portland, OregonOHSU Knight Cancer Institute
Jul 14, 2022
Iron Deficiency Anemia Trial in Waltham (Ferumoxytol)
Terminated
- Iron Deficiency Anemia
- Ferumoxytol
-
Waltham, MassachusettsAMAG Pharmaceuticals, Inc.
Mar 31, 2022
Iron Deficiency Anemia Trial in Waltham (Ferumoxytol, Oral Iron)
Terminated
- Iron Deficiency Anemia
- Ferumoxytol
- Oral Iron
-
Waltham, MassachusettsAMAG Pharmaceuticals, Inc.
Mar 31, 2022
Glioblastoma Trial in Columbus, Portland (Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging, Ferumoxytol,
Completed
- Glioblastoma
- Dynamic Susceptibility Contrast-Enhanced Magnetic Resonance Imaging
- +3 more
-
Columbus, Ohio
- +1 more
Mar 11, 2022
Brain Tumor Trial (Ferumoxytol, Magnetic Resonance Imaging)
Withdrawn
- Brain Neoplasm
- Ferumoxytol
- Magnetic Resonance Imaging
- (no location specified)
Nov 3, 2021
IC - Interstitial Cystitis Trial in Pittsburgh (Ferumoxytol, Gadobutrol)
Recruiting
- IC - Interstitial Cystitis
- Ferumoxytol
- Gadobutrol
-
Pittsburgh, PennsylvaniaUPMC Magee Women's Hospital
Apr 10, 2023
Hereditary Pancreatic Carcinoma, Pancreatic Adenocarcinoma, Pancreatic Intraductal Papillary-Mucinous Tumor Trial in Portland
Recruiting
- Hereditary Pancreatic Carcinoma
- +2 more
- Dynamic Contrast-Enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Aug 16, 2022
Osteonecrosis Trial in Stanford (Ferumoxytol-enhanced magnetic resonance imaging, Magentic Resonance Imaging)
Enrolling by invitation
- Osteonecrosis
- Ferumoxytol-enhanced magnetic resonance imaging
- Magentic Resonance Imaging
-
Stanford, CaliforniaLucile Packard Children's Hospital
Aug 19, 2021
Restless Legs Syndrome, Iron Deficiency Anemia Trial in Baltimore (Ferumoxytol intravenous, Ferrous sulfate)
Completed
- Restless Legs Syndrome
- Iron Deficiency Anemia
- Ferumoxytol intravenous
- Ferrous sulfate
-
Baltimore, MarylandAuerbach Hematology Oncology Assoc
Jul 20, 2022
Locally Advanced Rectal Carcinoma, Stage III Rectal Cancer AJCC v7, Stage IIIA Rectal Cancer AJCC v7 Trial in Portland
Terminated
- Locally Advanced Rectal Carcinoma
- +4 more
- Contrast-enhanced Magnetic Resonance Imaging
- Ferumoxytol
-
Portland, OregonOHSU Knight Cancer Institute
Sep 2, 2021
Stage IIB Esophageal Cancer AJCC v7, Stage III Esophageal Cancer AJCC v7, Stage IIIA Esophageal Cancer AJCC v7 Trial
Withdrawn
- Stage IIB Esophageal Cancer AJCC v7
- +4 more
- Ferumoxytol
- Magnetic Resonance Imaging
- (no location specified)
Sep 8, 2021
Anemia Trial in New York (Ferumoxytol injection)
Recruiting
- Anemia
- Ferumoxytol injection
-
New York, New YorkNYU Langone Health
Aug 11, 2022
Pediatric Congenital Heart Disease Trial in Los Angeles (ferumoxytol, gadofosveset)
Completed
- Pediatric Congenital Heart Disease
- ferumoxytol
- gadofosveset
-
Los Angeles, CaliforniaUCLA Medical Center
Nov 22, 2022